Submit Your Feeds

Business News • PR NewsWire • GlycoVaxyn's Staphylococcus aureus Bioconjugate Vaccine Candidate Protects Mice Against Invasive S. aureus Infection

GlycoVaxyn's Staphylococcus aureus Bioconjugate Vaccine Candidate Protects Mice Against Invasive S. aureus Infection
GlycoVaxyn's Staphylococcus aureus Bioconjugate Vaccine Candidate Protects Mice Against Invasive S. aureus Infection

CHICAGO, Sept. 16, 2011 /PRNewswire/ -- GlycoVaxyn AG, a leader in the development of innovative vaccines, today announced an abstract to be presented on a glycoprotein vaccine based on recombinant DNA technology to prevent Staphylococcus aureus infection at the 51st Interscience...

View More : http://www.prnewswire.com/news-releases/glycovaxyns-staphylococcus-aureus-bioconjugate-vaccine-candidate-protects-mice-a...
Releted News by prnewswire
GlycoVaxyn's Staphylococcus aureus Bioconjugate Vaccine Candidate Protects Mice Against Invasive S. aureus Infection
Brits say Hospital Parking Charges Top Chart of Sneaky Extras
Diskeeper Corporation's Appointment of new CEO Jerry Baldwin Driven by Growth of Virtualization and Private Cloud
Home Sitemap Contact Us
© businessNewsNewsNews.com